Table 1 Patient characteristics
From: Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas
Multiple (n = 34) | Single | |||
|---|---|---|---|---|
Pure GGN (n = 17) | Part Solid (n = 40) | Solid (n = 68) | ||
Age, (years) | 73.7 ± 7.9 | 65.0 ± 11.2 | 71.3 ± 13.0 | 71.6 ± 9.4 |
Gender, (male/female), n | 18/16 | 8/9 | 22/18 | 31/37 |
Previous cancer history, (Yes), n | 3 (9) | 4 (24) | 11 (28) | 13 (19) |
Surgical procedure, n | ||||
Operation | ||||
Open Thoractomy | 0 | 0 | 0 | 0 |
Video-assisted thoracoscopy | 34 (100) | 17 (100) | 40 (100) | 68 (100) |
Resection type | ||||
Wedge resection | 7 (20) | 10 (59) | 5 (12) | 4 (6) |
Segmentectomy | 0 | 0 | 3 (8) | 1 (1) |
Lobectomy | 19 (37) | 7 (41) | 32 (80) | 62 (92) |
Combination | 8 (23) | 0 | 0 | 1 (1) |
Fatal complications | 0 | 0 | 0 | 2 (3) |
Histology, n | ||||
Adenocarcinoma in situ | 15 (44) | 15 (88) | 9 (22) | 1 (1) |
Minimally-invasive adenocarcinoma | 1 (3) | 2 (12) | 3 (8) | 0 |
Invasive adenocarcinoma | 17 (50) | 0 | 26 (65) | 59 (87) |
Variants of invasive adenocarcinoma | 1 (3) | 0 | 2 (5) | 8 (12) |
Chemotherapy, n | ||||
None | 27 (79) | 17 (100) | 31 (78) | 32 (47) |
UFT | 6 (18) | 0 | 9 (22) | 31 (46) |
Cisplatin based chemotherapy | 1 (3) | 0 | 0 | 5 (7) |
Dominant Tumor Size (mm) | 23.7 ± 13.9 | 10.9 ± 4.6 | 19.4 ± 7.9 | 28.8 ± 20.1 |
pStage Ia, n | 24 (70) | 17 (100) | 35 (87) | 40 (59) |
Stage Ib, n | 6 (18) | 0 | 4 (10) | 23 (34) |
Stage IIa, n | 4 (12) | 0 | 1 (3) | 4 (6) |
pStage IIb, n | 0 | 0 | 0 | 1 (1) |